Press release
AI in Biopharmaceutical Development Market Revenue Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI in Biopharmaceutical Development Market- by Type (Monoclonal Antibodies, Vaccines, and Recombinant Proteins), Application (Research and Discovery, Clinical Development, Manufacturing & Supply Chain and Other Subsegments), End-User (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations or Contract Research Organizations (CRO), and Academic & Government Research Institutes), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."According to the latest research by InsightAce Analytic, the global AI in the Biopharmaceutical Development market is valued at US$ 452.33 Million in 2021, and it is expected to reach US$ 16.4 Billion by 2030, with a CAGR of 49.3% during a forecast period of 2022-2030.
Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/1227
The frontier technology most likely to have a game-changing influence on the biopharmaceutical industry is artificial intelligence (AI). AI method domains (ML) include reasoning, solution search, knowledge representation, and machine learning. It can help with decision-making, selecting the best course of treatment for a patient, customizing medications, and maintaining clinical data for future drug research. In drug discovery, AI can differentiate between hit and lead compounds, enabling quicker therapeutic target confirmation and structural design optimization.
The market is expanding as artificial intelligence gains popularity in the biopharmaceutical sector. Rising medication research expenses and greater awareness of AI's efficacy will also be significant market growth drivers in the upcoming years. A low trial failure rate, an abundance of software developers for drug discovery, and a high demand for software among big pharma & biotech businesses and research institutes are also contributing to the market's growth. Adopting AI technologies shortens the length of the clinical trial cycle, removes potential roadblocks, and increases efficiency and accuracy. The most significant issues in this industry for AI-based biopharmaceutical development are the higher costs of the equipment, applications, and software. Other market barriers for the projection period include a lack of data sets for medication discovery, a shortage of experienced workers, and a lack of rules and ethical standards for using artificial intelligence in healthcare.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1227
Due to many software and technology vendors, North America is anticipated to mainly contribute to AI in the Biopharmaceutical Development market over the forecast years. Additionally, the growing prevalence of chronic diseases and rising costs for R&D activities in the United States drive the North American biopharmaceuticals market. The United States is the centre of the world's life sciences innovations and actively participates in biopharmaceutical companies' influential global capital investments. In addition, the Asia Pacific AI in Biopharmaceutical Development market is expected to grow significantly during the forecast period. One of the main factors influencing the market is the expansion of international market players into Asian markets such as China, India, and others. Due to this region's low manufacturing and operating costs, Asian nations are also becoming more popular as a hub for biomanufacturing new medicines.
Major market players operating in AI in the biopharmaceutical Development market include IBM Watson Health, Google (Alphabet Inc.), Concreto HealthAI, Nvidia Corporation, PathAI, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Ai-biopharma S.A.S., and Microsoft Corporation, among others, are some key players operating in the AI in Biopharmaceutical Development Market.
Recent collaborations and agreements in the market:
• In April 2021, Microsoft acquired Nuance for $19.7 billion, emphasizing healthcare AI. Microsoft will pay Nuance $19.7 billion in cash. With Nuance's conversational AI and speech recognition technologies under its wing, Microsoft will step up its effort to provide cloud-based AI solutions to the healthcare sector on a larger scale.
• In April 2021, On AI-driven drug discovery, Nvidia worked with AstraZeneca and the University of Florida. Through this partnership, researchers will be able to more quickly assess billions of compounds for possible therapeutic candidates thanks to a model trained using the AI supercomputer Nvidia DGX SuperPOD.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1227
Market Segments
Global AI in Biopharmaceutical Development Market, by Type, 2022-2030 (Value US$ Mn)
• Monoclonal antibodies
• Vaccines
• Recombinant proteins
Global AI in Biopharmaceutical Development Market, by Application, 2022-2030 (Value US$ Mn)
• Research and discovery
• Clinical development
• Manufacturing & supply chain and other subsegments
Global AI in Biopharmaceutical Development Market, by End-User, 2022-2030 (Value US$ Mn)
• Biopharmaceutical manufacturers
• Contract manufacturing organizations (CMOs) or contract research organizations (CROs)
• Academic & government research institutes
Global AI in Biopharmaceutical Development Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America AI in Biopharmaceutical Development Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe AI in Biopharmaceutical Development Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific AI in Biopharmaceutical Development Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America AI in Biopharmaceutical Development Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa AI in Biopharmaceutical Development Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global AI in Biopharmaceutical Development market
To receive an industry overview and future trends of the AI in Biopharmaceutical Development market
To analyze the AI in Biopharmaceutical Development market drivers and challenges
To get information on the AI in Biopharmaceutical Development market value (US$Mn) forecast to 2030
Significant investments, mergers & acquisitions in the AI in Biopharmaceutical Development market industry
Get more information: @
https://www.insightaceanalytic.com/report/global-ai-in-biopharmaceutical-development-market-/1227
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Biopharmaceutical Development Market Revenue Report with Forecast to 2031 here
News-ID: 3807495 • Views: …
More Releases from Insightace Analytic Pvt Ltd.

4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…

Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…

E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…

E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for Biopharmaceutical
Biopharmaceutical third-party logistics Market
Biopharmaceutical Third-Party Logistics Market to reach over USD 176.28 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), Region, Market Outlook And Industry Analysis 2031"
The global Biopharmaceutical third-party logistics market…
Biopharmaceutical Fermentation Market Fueling Biopharmaceutical Innovation: The …
Biopharmaceutical Fermentation Market Worth USD 14.91billion by the year 2030- Exclusive Report by InsightAce Analytic
The newly published report titled "Global Biopharmaceutical Fermentation Market (By Product (Upstream And Downstream Processes), Application (Antibiotics, Recombinant Proteins, Monoclonal Antibodies, Probiotics, And Others), End-User (Biopharmaceutical Industries, Contract Research
Organizations, Food Industries, Academic Research Institutes, And Others))- Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) And Forecast Till 2030." of InsightAce Analytic Pvt. Ltd.…
Biopharmaceutical Cold Chain Transport Market Temperature-controlled Transport f …
Biopharmaceutical Cold Chain Transport Market 2023 Forecast: Unveiling Opportunities and Growth
Biopharmaceutical Cold Chain Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Cold Chain Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of…
Biopharmaceutical Transport Market Transport Se rvices for Biopharmaceutical Pro …
Biopharmaceutical Transport Market 2023 Forecast: Unveiling Opportunities and Growth
Biopharmaceutical Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including the volume of…
Biopharmaceutical Market Industry Analysis - Biopharmaceutical Market Size Drive …
Acumen Research and Consulting has recently published a research report on the Biopharmaceutical Market for the forecast period of 2022 - 2030, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Biopharmaceutical Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2030.
The research study on the Biopharmaceutical Market analyzes key drivers upholding product sales…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…